Select a section from the left sidebar
(2R,3S,4S,5R,6R,8S,9R,10R,11S,13R,14R,17R,1′S,2′R,3′R,5′R)-4,8,11,14-tetrahydroxy-5,6-epoxy-12-oxo- 2-O,3-O-[(2′,3′-methylendioxy)-4′,6′-didesoxyhexosulose]-card-20 (22)-enolide
- Family: Plantae - Celastraceae
- Kingdom: Plantae
- Class: Steroid
Canonical Smiles | CC1C[C@H]2OCO[C@]32[C@@H](O1)O[C@H]1[C@H](O3)C[C@]2([C@]3([C@H]1O)O[C@@H]3C[C@@]1(C2[C@H](O)C(=O)[C@]2([C@]1(O)CC[C@@H]2C1=CC(=O)OC1)C)O)C |
---|---|
InChI | InChI=1S/C30H38O13/c1-12-6-16-30(39-11-38-16)24(40-12)41-20-15(42-30)8-25(2)21-19(32)22(33)26(3)14(13-7-18(31)37-10-13)4-5-28(26,36)27(21,35)9-17-29(25,43-17)23(20)34/h7,12,14-17,19-21,23-24,32,34-36H,4-6,8-11H2,1-3H3/t12?,14-,15-,16-,17-,19+,20+,21?,23+,24+,25-,26+,27+,28-,29+,30+/m1/s1 |
InChIKey | OFYFSRGXSZVPKF-NSWPUUHSSA-N |
Formula | C30H38O13 |
HBA | 13 |
HBD | 4 |
MW | 606.62 |
Rotatable Bonds | 1 |
TPSA | 182.97 |
LogP | -0.79 |
Number Rings | 9 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Fraction CSP3 | 0.87 |
Exact Mass | 606.23 |
Number of Lipinski Rule Violations | 2 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Salacia staudtiana | Celastraceae | Plantae | 662028 |
Showing of synonyms
(2R,3S,4S,5R,6R,8S,9R,10R,11S,13R,14R,17R,1′S,2′R,3′R,5′R)-4,8,11,14-tetrahydroxy-5,6-epoxy-12-oxo- 2-O,3-O-[(2′,3′-methylendioxy)-4′,6′-didesoxyhexosulose]-card-20 (22)-enolide
No compound-protein relationship available.
SMILES: C1OC(=O)C=C1C(CC2)C(C2C3CC(C456)O6)C(=O)CC3C4CC7C(C5)OC8C9(O7)C(CCO8)OCO9
Level: 1
Mol. Weight: 606.62 g/mol
SMILES: C123C(O3)CC4C5C(CCC5)C(=O)CC4C1CC6C(C2)OC7C8(O6)C(CCO7)OCO8
Level: 0
Mol. Weight: 606.62 g/mol
SMILES: O=C1C=CCO1
Level: 0
Mol. Weight: 606.62 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -5.48
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.88
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Substrate
- Skin Permeability
- 15.45
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.31
- Plasma Protein Binding
- 51.68
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 4.02
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -2.29
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Safe
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- -1.07
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 5.97
- Micronucleos
- Toxic
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Toxic
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Toxic
- T. Pyriformis
- -29870.99
- Rat (Acute)
- 5.16
- Rat (Chronic Oral)
- 3.0
- Fathead Minnow
- 52.35
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Toxic
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Toxic
General Properties
- Boiling Point
- 769.58
- Hydration Free Energy
- -2.92
- Log(D) at pH=7.4
- 0.91
- Log(P)
- -0.68
- Log S
- -2.82
- Log(Vapor Pressure)
- -13.35
- Melting Point
- 219.55
- pKa Acid
- 4.4
- pKa Basic
- 1.79
Protein Name | UniProt ID | Entry Name | Species | #Pharmacophore Points | Probability (0.7 ≤ Tversky Score ≤ 1.0) |
---|---|---|---|---|---|
Xylose isomerase | P24300 | XYLA_STRRU | Streptomyces rubiginosus | 3 | 0.8807 |